Cassava Sciences Inc. sell stratec
Start price
27.06.18
/
50%
€1.95
Target price
02.07.18
€1.53
Performance (%)
-4.63%
End price
02.07.18
€1.86
Summary
This prediction ended on 02.07.18 with a price of €1.86. With a performance of -4.63%, the SELL prediction for Cassava Sciences Inc. by stratec was down slightly. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -23.088% | -23.088% | -19.375% | -93.771% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |
Comments by stratec for this prediction
In the thread Cassava Sciences Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' nicht zu
stratec stimmt am 27.06.2018 dem Buy-Gesamtsentiment mit dem Kursziel 9.0$ nicht zu.
- A joint FDA panel has voted against approval for Pain Therapeutics Remoxy ER treatment.
(Vom Mitglied beendet)